SMTL ID : 9mr9.7 (7 other biounits)

Crystal structure of AU-15330 in complex with the bromodomain of human BRM (SMARCA2) and pVHL:ElonginC:ElonginB

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.30 Å

Oligo State

hetero-1-1-1-1-mer

Ligands

1 x 01: N-({4-[(6M)-3-amino-6-(2-hydroxyphenyl)pyridazin-4-yl]piperazin-1-yl}acetyl)-3-methyl-L-valyl-(4R)-4-hydroxy-N-{(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl}-L-prolinamide

01.1: 25 residues within 4Å: Chain A: E.36, V.37, F.38, E.46, L.47, Y.50, V.58, L.85, A.89, F.92, N.93 Chain B: R.17, P.34, W.36, F.39, Y.46, P.47, L.49, R.55, I.57, H.58, S.59, Y.60, H.63, W.65 15 PLIP interactions: 10 interactions with chain B, 5 interactions with chain A Hydrophobic interactions: B:W.36, B:Y.46, B:Y.46, B:I.57, B:W.65, A:E.46, A:L.85 Hydrogen bonds: B:Y.46, B:R.55, B:H.58, B:Y.60, B:W.65, A:N.93, A:N.93 pi-Stacking: A:F.38

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hulse, M. et al., PRT3789 is a First-in-Human SMARCA2-Selective Degrader that Induces Synthetic Lethality in SMARCA4-Mutated Cancers. Cancer Res. (2025)

Release Date

2025-10-08

Peptides

Isoform Short of Probable global transcription activator SNF2L2: A
von Hippel-Lindau disease tumor suppressor: B
Elongin-C: C
Elongin-B: D

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
Y

B
Z

C
a

D
b

Isoform Short of Probable global transcription activator SNF2L2

von Hippel-Lindau disease tumor suppressor

Elongin-C

Elongin-B

Related Entries With Identical Sequence